×

What are you searching for?




Healthcare

4 Min read

SANTEN OBTAINS US FDA ACCEPTANCE OF PMA APPLICATION FOR DE-128

Published On 10 Jul 2020 10:28 AM


SHARE THIS ARTICLE  


HIGHLIGHTS

  • Santen Pharmaceutical Co., Ltd. has submitted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.
  • US FDA has accepted the application from Santen.
  • DE-128 is an investigational surgical glaucoma implant.

The United States Food and Drug Administration (US FDA) has accepted the Premarket Approval (PMA) application from Santen Pharmaceuti....


Tags : United States Food and Drug Administration, USFDA, Santen Pharmaceutical Co. Ltd., DE-128, Premarket Approval, PMA, primary open-angle glaucoma, POAG ,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)